Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model.

Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model.

Item
http://www.wikidata.org/entity/Q40949443
Neoadjuvant therapy for gastric cancer: current evidence and future directionsMultimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.The Effect of Neoadjuvant Chemoradiation on Anastomotic Leak and Additional 30-Day Morbidity and Mortality in Patients Undergoing Total Gastrectomy for Gastric Cancer.Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer.Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer.Optimal management of resected gastric cancer.
P2860

Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model.

Item
http://www.wikidata.org/entity/Q40949443
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Omission of adjuvant therapy a ...... ent of a validated risk model.
@en
type
label
Omission of adjuvant therapy a ...... ent of a validated risk model.
@en
prefLabel
Omission of adjuvant therapy a ...... ent of a validated risk model.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Omission of adjuvant therapy a ...... ent of a validated risk model.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698